Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study

BACKGROUND: Data on the effectiveness of the 3-dose mRNA-1273 primary series are limited, particularly in comparison to 2 doses. Given suboptimal COVID-19 vaccine uptake among immunocompromised populations, it is important to monitor the effectiveness of fewer than the recommended doses in this popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Jennifer H., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Tubert, Julia E., Lee, Gina S., Florea, Ana, Bruxvoort, Katia J., Talarico, Carla A., Qiu, Sijia, Tian, Yun, Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154542/
https://www.ncbi.nlm.nih.gov/pubmed/37173268
http://dx.doi.org/10.1016/j.vaccine.2023.04.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154542/
https://www.ncbi.nlm.nih.gov/pubmed/37173268
http://dx.doi.org/10.1016/j.vaccine.2023.04.075

Ejemplares similares